|
|
Article: Staphylococcus aureus with Reduced Susceptibility to Vancomycin -- Illinois, 1999.
- Article from:
- MMWR. Morbidity and Mortality Weekly Report
- Article date:
- January 7, 2000
CopyrightCOPYRIGHT 2000 U.S. Government Printing Office. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staphylococcus aureus is one of the most common causes of hospital- and community-acquired infections. Nosocomial methicillin-resistant S. aureus (MRSA) infections have become common, and cases of community-acquired MRSA infections also have occurred [1,2]. Since 1996, vancomycin-intermediate S. aureus(VISA; vancomycin minimum inhibitory concentration [MIC]=8-16 [micro]g/mL) has been identified in Europe, Asia, and the United States [3-5]. The emergence of reduced vancomycin susceptibility in S. aureus increases the possibility that some strains will become fully resistant and that available antimicrobial agents will become ineffective for treating infections caused by ...